Addus HomeCare (NASDAQ:ADUS) initiated with Outperform rating at William Blair.
Denali Therapeutics (NASDAQ:DNLI) initiated with Buy rating and $30 (57% upside) price target at BTIG Research.
Cronos Group (NASDAQ:CRON) upgraded to Buy with a C$22 (20% upside) price target at PI Financial. Upgraded to Hold with a C$17 price target at Canaccord.
Avedro (NASDAQ:AVDR) downgraded to Market Perform with a $27 (16% upside) price target at Cowen and Company.
Corindus Vascular Robotics (NYSEMKT:CVRS) downgraded to Market Perform with a $4.28 (flat) price target at Cowen. Shares down 1% premarket.
Nektar Therapeutics (NASDAQ:NKTR) downgraded to Hold with a $23 (22% downside risk) price target at Jefferies. Downgraded to Neutral with a $33 price target at JPMorgan. Downgraded to Neutral at Mizuho Securities. Shares down 30% premarket on concerns of diminishing patient responses to NKTR-214 (bempegaldesleukin).
Wright Medical Group (NASDAQ:WMGI) downgraded to Neutral with a $25 (14% upside) price target at BofA Merrill Lynch. Shares down 5% premarket after Q2 miss and guidance cut.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.